Mitsubishi Motors Reports Second Quarter 2022 Sales, Outlander Sales Performance Continues to Lead the Way
Mitsubishi Tanabe Pharma America Presents Real-World Data on RADICAVA® (edaravone) at 2022 American Academy of Neurology Annual Meeting
2023 Eclipse Cross To Feature Standard Super All-wheel Control; Mitsubishi Motors Announces Pricing And Specifications
Mitsubishi Tanabe Pharma America to Showcase ALS Research at 2022 American Academy of Neurology Annual Meeting
Mitsubishi Tanabe Pharma America Highlights ALS Research at 2022 MDA Clinical & Scientific Conference